Xarelto (rivaroxaban) is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in July 2011 to prevent strokes in patients who received hip and knee replacements. In November 2011, the approval was expanded to any patients with atrial fibrillation (irregular heartbeat). Xarelto has been widely prescribed, with millions of people taking the medication since it entered the market.
The number of lawsuits alleging injuries associated with ingestion of Xarelto continues to grow in the United States. Regulators in Canada recently announced investigations into reports of liver injuries that may be associated with Xarelto usage. The August 26 safety review cites numerous reports of liver injuries among Xarelto users. The Canadian government will continue to monitor the safety information involving Xarelto to assess the health risks of the medication.
The attorneys at Stark & Stark continue to pursue all legal redress available in the federal action, as well as state actions in Pennsylvania and New Jersey, for the benefit of its clients that have suffered injuries resulting from their use of Xarelto. If you feel you have experienced any side-effects from taking Xarelto, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the manufacturers of Xarelto.